• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 04, 2024 at 11:42: AM
via A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has returned with an endorsement in obesity.

article source
 

<



Similar threads

cafead
Tandem wins clearance for t:slim X2 pump with Eli Lilly fast-acting insulin in Europe
Replies
0
Views
3
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor
Replies
0
Views
72
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Lilly wins FDA approval for second interchangeable insulin biosimilar
Replies
0
Views
195
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novartis wins on quantity, but Eli Lilly takes the cake on value of new launches: report
Replies
0
Views
223
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity
Replies
0
Views
142
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote